NanoBioNexus and Morrison & Foerster LLP will be sponsoring the event Nanofabrication: What Can Self-Assembly do for Nanotech Applications? on Thursday, March 23, 2006 at 5:30 p.m. at Morrison & Foerster, 12531 High Bluff Drive, Suite 100, San Diego, CA 92130. the event will focus on creating nanoscale architectures through molecular recognition and self-assembly. The speakers will include Mihri Ozkan, Ph.D., Assistant Professor, Department of Electrical Engineering, Center for Nanoscale Science and Engineering, University of California Riverside, and Cengiz S. Ozkan, Ph.D., Assistant Professor, Department of Mechanical Engineering, University of California Riverside.
The Elective for the Third Annual Global Bioexecutive Program, Managing Scientists and Technical Staff, will be held on March 17, 2006 at the UC Berkeley Haas School of Business. The module will address such topics as what scientists learned in graduate school, what scientists need to know to succeed in business, transforming single contributors into team players, overcoming impediments to productivity in research and development, negotiating skills for scientists, conflict resolution, dealing with difficult people and situations, and developing effective professional development programs for technical staff.
The event Healthcare/Bio-Science Summit & Spring Venture Forum: New Frontiers in Medicine will be held from 8 a.m. to 10 a.m. at the Doubletree Hotel, San Jose, 2050 Gateway Place, San Jose, CA 95110. The panel at this event will discuss healthcare issues affecting businesses in Silicon Valley. Panelists will include: Sam Collela, Managing Partner, Versant Ventures; Richard Levy, CEO of Varian Medical Systems; Martha Marsh, President and CEO of Stanford Hospital & Clinics; and David S. Sobel, MD, MPH, Director, Patient Education and Health Promotion, Kaiser Permanente, North California. The event will also provide time to pitch ideas to a VC/Angel Investor, which will be sponsored by the Silicon Valley/San Jose Business Journal in partnership with The Enterprise Network of Silicon Valley.
The event Harlan Lunch & Learn: Polyclonal Antibody Production will be held on Thursday, March 16th, 2006 from 11:30 a.m. to 1:30 p.m. at the BIOCOM/McGraw Conference Room, 4510 Executive Drive, Plaza 7, San Diego, CA 92121. Topics will include antigen development, in-vivo model options and purification /conjugation methods pertaining to polyclonal antibody development.
The event Healthcare/Bio-Science Summit & Spring Venture Forum: New Frontiers in Medicine will be held from 8 a.m. to 10 a.m. at the Doubletree Hotel, San Jose, 2050 Gateway Place, San Jose, CA 95110. The panel at this event will discuss healthcare issues affecting businesses in Silicon Valley. Panelists will include: Sam Collela, Managing Partner, Versant Ventures; Richard Levy, CEO of Varian Medical Systems; Martha Marsh, President and CEO of Stanford Hospital & Clinics; and David S. Sobel, MD, MPH, Director, Patient Education and Health Promotion, Kaiser Permanente, North California. The event will also provide time to pitch ideas to a VC/Angel Investor, which will be sponsored by the Silicon Valley/San Jose Business Journal in partnership with The Enterprise Network of Silicon Valley.
The event Harlan Lunch & Learn: Polyclonal Antibody Production will be held on Thursday, March 16th, 2006 from 11:30 a.m. to 1:30 p.m. at the BIOCOM/McGraw Conference Room, 4510 Executive Drive, Plaza 7, San Diego, CA 92121. Topics will include antigen development, in-vivo model options and purification /conjugation methods pertaining to polyclonal antibody development.
The event Specialty Pharmaceuticals–Licensing & IP Strategies for Faster Value Creation will be held on Tuesday, March 14, 2006 from 6 to 8 p.m. at the Marriott La Jolla, Salons A & B, 4240 La Jolla Village Drive, San Diego. The program will examine the next step for the specialty pharma business model. Speakers will include Laurent Fischer, President & CEO of Ocera Therapeutics; Bob More, Partner of Domain Associates; Karen Dow, Partner at Townsend and Townsend and Crew LLP; and Richard K. Masterson Jr., VP of Global Commercial Development at Valeant Pharmaceuticals International. The moderator is David Palella, President of BioScience Ventures, Inc.
The University of California Extension in Silicon Valley Cupertino, CA will hold Clinical Trials Essentials: An Intensive Course on March 13-17, 2006. The course will focus on elements of clinical trial design and management, including drug and device development processes, trial design, regulation of clinical research, roles and responsibilities of key players, trial monitoring, data management, safety reporting, and the business of clinical research.
The event Specialty Pharmaceuticals–Licensing & IP Strategies for Faster Value Creation will be held on Tuesday, March 14, 2006 from 6 to 8 p.m. at the Marriott La Jolla, Salons A & B, 4240 La Jolla Village Drive, San Diego. The program will examine the next step for the specialty pharma business model. Speakers will include Laurent Fischer, President & CEO of Ocera Therapeutics; Bob More, Partner of Domain Associates; Karen Dow, Partner at Townsend and Townsend and Crew LLP; and Richard K. Masterson Jr., VP of Global Commercial Development at Valeant Pharmaceuticals International. The moderator is David Palella, President of BioScience Ventures, Inc.
The Inaugural Stem Cell Meeting will be held on March 12-14 at the Palace Hotel in San Francisco, CA. The event is the premier international event bringing together world renowned scientists at the frontier of embryonic and adult stem cell research with decision makers and thought leaders in policy, ethics, patient advocacy, finance, business, and media to explore the challenge and promise of stem cell research and the compelling potential of emerging therapies.
